Natco Pharma, along with its marketing partner Arrow International, recently launched the first generic of Revlimid in dosage strengths of 5 mg, 10 mg, 15 mg and 25 mg.
Thirty-five generic manufacturers have signed agreements with the MPP to produce low-cost, generic versions of Pfizer’s oral COVID-19 treatment nirmatrelvir in combination with ritonavir for 95 low- and middle-income countries.
Breyna is used to treat asthma in patients aged 6 years old and older, and in the maintenance treatment of airflow obstruction and reducing exacerbations for patients with COPD.
Nystatin and Triamcinolone Acetonide are used for the treatment of cutaneous candidiasis, which is an infection of the skin and nails caused by the candida fungus.